Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erik Michael

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
Ugeskrift for Laeger|March 23, 2011
[Strengthening of laboratories is a new component in the global strategy for tuberculosis control]Vibeke Østergaard Thomsen, Didi Bang, Zaza Kamper-Jørgensen, et al.
International Journal of Systematic and Evolutionary Microbiology|January 8, 2025
Four novel nontuberculous mycobacteria species: <i>Mycobacterium wendilense</i> sp. nov., <i>Mycobacterium burgundiense</i> sp. nov., <i>Mycobacterium kokjensenii</i> sp. nov. and <i>Mycobacterium holstebronense</i> sp. nov. revived from a historical Danish strain collectionXenia Emilie Sinding Iversen, Erik Michael Rasmussen, Dorte Bek Folkvardsen, et al.
Journal of Clinical Microbiology|March 1, 2013
Can molecular methods detect 1% isoniazid resistance in Mycobacterium tuberculosis?Dorte Bek Folkvardsen, Erik Svensson, Vibeke Ø Thomsen, et al.
Ebiomedicine|August 18, 2019
Direct transmission of within-host Mycobacterium tuberculosis diversity to secondary cases can lead to variable between-host heterogeneity without de novo mutation: A genomic investigationMarie Nancy Séraphin, Anders Norman, Erik Michael Rasmussen, et al.
Journal of Clinical Microbiology|April 20, 2026
Seven decades of nontuberculous mycobacteria in Denmark: shifts in species distribution and clinical relevanceXenia Emilie Sinding Iversen, Anders Norman, Dorte Bek Folkvardsen, et al.
Journal of Clinical Microbiology|September 27, 2013
Rifampin heteroresistance in Mycobacterium tuberculosis cultures as detected by phenotypic and genotypic drug susceptibility test methodsDorte Bek Folkvardsen, Vibeke Ø Thomsen, Leen Rigouts, et al.
Scientific Reports|April 25, 2017
An attenuated Mycobacterium tuberculosis clinical strain with a defect in ESX-1 secretion induces minimal host immune responses and pathologyHelena Strand Clemmensen, Niels Peter Hell Knudsen, Erik Michael Rasmussen, et al.
Jac-Antimicrobial Resistance|October 6, 2023
Resistance patterns and transmission of mono- and polyresistant TB: clinical impact of WGSMatúš Dohál, Věra Dvořáková, Miluše Šperková, et al.
BMC Infectious Diseases|September 30, 2024
The impact of an oral glucose load on IFN-γ-release in persons infected with Mycobacterium tuberculosisHans Johan Niklas Lorentsson, Christina Reinholdt Clausen, Daniel Faurholt-Jepsen, et al.
Scientific Reports|May 3, 2022
Whole genome sequencing of multidrug-resistant Mycobacterium tuberculosis isolates collected in the Czech Republic, 2005-2020Matúš Dohál, Věra Dvořáková, Miluše Šperková, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Ugeskrift for Laeger|March 23, 2011
[Strengthening of laboratories is a new component in the global strategy for tuberculosis control]Vibeke Østergaard Thomsen, Didi Bang, Zaza Kamper-Jørgensen, et al.
International Journal of Systematic and Evolutionary Microbiology|January 8, 2025
Four novel nontuberculous mycobacteria species: <i>Mycobacterium wendilense</i> sp. nov., <i>Mycobacterium burgundiense</i> sp. nov., <i>Mycobacterium kokjensenii</i> sp. nov. and <i>Mycobacterium holstebronense</i> sp. nov. revived from a historical Danish strain collectionXenia Emilie Sinding Iversen, Erik Michael Rasmussen, Dorte Bek Folkvardsen, et al.
Journal of Clinical Microbiology|March 1, 2013
Can molecular methods detect 1% isoniazid resistance in Mycobacterium tuberculosis?Dorte Bek Folkvardsen, Erik Svensson, Vibeke Ø Thomsen, et al.
Ebiomedicine|August 18, 2019
Direct transmission of within-host Mycobacterium tuberculosis diversity to secondary cases can lead to variable between-host heterogeneity without de novo mutation: A genomic investigationMarie Nancy Séraphin, Anders Norman, Erik Michael Rasmussen, et al.
Journal of Clinical Microbiology|April 20, 2026
Seven decades of nontuberculous mycobacteria in Denmark: shifts in species distribution and clinical relevanceXenia Emilie Sinding Iversen, Anders Norman, Dorte Bek Folkvardsen, et al.
Journal of Clinical Microbiology|September 27, 2013
Rifampin heteroresistance in Mycobacterium tuberculosis cultures as detected by phenotypic and genotypic drug susceptibility test methodsDorte Bek Folkvardsen, Vibeke Ø Thomsen, Leen Rigouts, et al.
Scientific Reports|April 25, 2017
An attenuated Mycobacterium tuberculosis clinical strain with a defect in ESX-1 secretion induces minimal host immune responses and pathologyHelena Strand Clemmensen, Niels Peter Hell Knudsen, Erik Michael Rasmussen, et al.
Jac-Antimicrobial Resistance|October 6, 2023
Resistance patterns and transmission of mono- and polyresistant TB: clinical impact of WGSMatúš Dohál, Věra Dvořáková, Miluše Šperková, et al.
BMC Infectious Diseases|September 30, 2024
The impact of an oral glucose load on IFN-γ-release in persons infected with Mycobacterium tuberculosisHans Johan Niklas Lorentsson, Christina Reinholdt Clausen, Daniel Faurholt-Jepsen, et al.
Scientific Reports|May 3, 2022
Whole genome sequencing of multidrug-resistant Mycobacterium tuberculosis isolates collected in the Czech Republic, 2005-2020Matúš Dohál, Věra Dvořáková, Miluše Šperková, et al.
Pageof 4